Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

111.04 -2.06 (-1.82%)

Official Closing Price Updated: 6:30 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

53 54 Next >

3 Magnificent Dividend Growth Stocks to Buy Now and Hold for at Least a Decade ↗

February 27, 2024

These stocks don't offer the highest yields, but their payouts are growing fast.

Via The Motley Fool

3 Blue-Chip Stocks to Buy to Bolster Your Portfolio ↗

February 26, 2024

Delve into three undervalued blue-chip stocks to buy driving growth in consumer staples, pharmaceuticals, and healthcare.

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 26, 2024

Via Benzinga

Could Abbott Laboratories Stock Help You Become a Millionaire? ↗

February 26, 2024

Abbott's earnings have soared over the past decade.

Via The Motley Fool

Looking for Growth? 7 Hot Trends That Have Been Flying Under Investors’ Radar. ↗

February 26, 2024

Discover 7 under-the-radar stock trends set to make waves in the stock market. Find out why savvy investors are tuning in.

Via InvestorPlace

Abbott Laboratories (NYSE: ABT) Records 52-Week High Friday Morning

February 23, 2024

Via Investor Brand Network

Abbott Laboratories Options Trading: A Deep Dive into Market Sentiment ↗

February 23, 2024

Via Benzinga

Peering Into Abbott Laboratories's Recent Short Interest ↗

February 20, 2024

Via Benzinga

Recession-Proof Riches: 7 Stocks to Buy for Bulletproof Portfolio Growth ↗

February 23, 2024

Explore recession-proof stocks thriving in Energy, Health Care, Industrials, and more, offering stability and growth amid economic turmoil.

Via InvestorPlace

Abbott Laboratories Stock Gets A Healthy Technical Rating Upgrade ↗

February 21, 2024

In a welcome move, Abbott Laboratories stock saw its Relative Strength Rating improve from 67 to 73 on Wednesday.

Via Investor's Business Daily

3 Cash Cows to Boost Your Confidence During the February Chill ↗

February 18, 2024

The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.

Via InvestorPlace

The Smartest Dividend Stocks to Buy With $400 Right Now ↗

February 18, 2024

These stocks reward you during any market environment.

Via The Motley Fool

Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device ↗

February 14, 2024

FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024.

Via Benzinga

This Is What Whales Are Betting On Abbott Laboratories ↗

February 08, 2024

Via Benzinga

Is Abbott Laboratories Stock a Buy Now? ↗

February 03, 2024

Can Abbott Laboratories be a reliable income stock to hang on to now?

Via The Motley Fool

Looking At Abbott Laboratories's Recent Unusual Options Activity ↗

January 30, 2024

Via Benzinga

FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom ↗

February 12, 2024

FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.

Via Benzinga

Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How. ↗

February 11, 2024

Abbott Labs has an impressive portfolio of nutrition drinks, and its latest addition could help it profit from a new market: people taking prescribed weight loss drugs.

Via The Motley Fool

3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗

February 11, 2024

Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.

Via InvestorPlace

These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys? ↗

February 09, 2024

There's room for multiple winners in the fast-growing weight-loss market.

Via The Motley Fool

Abbott Laboratories Stock Getting Closer To Key Technical Benchmark ↗

February 07, 2024

Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Via Investor's Business Daily

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates ↗

February 07, 2024

When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.

Via InvestorPlace

Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever ↗

February 07, 2024

Healthcare is an excellent place to find some tried and true wealth compounders.

Via The Motley Fool

Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗

February 05, 2024

Healthcare stocks usually provide a defensive posture to a stock portfolio.

Via Talk Markets

Topics ETFs

2 Stocks to Buy Near Their 52-Week Highs ↗

February 05, 2024

It's not too late to invest in these stocks.

Via The Motley Fool

2 Healthcare Dividend Kings to Buy and Hold Forever ↗

February 04, 2024

It's going to take a lot to interrupt these companies' streaks.

Via The Motley Fool

Abbott Faces Lawsuit As Grandmother Questions PediaSure's Height Growth Claims ↗

February 03, 2024

Abbott Laboratories faces a lawsuit questioning the efficacy of PediaSure Grow & Gain nutrition drinks in promoting height growth.

Via Benzinga

Topics Lawsuit

Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market? ↗

February 02, 2024

Abbott Labs is using its well-established strengths to make gains in the weight loss market.

Via The Motley Fool

4 med tech stocks with improving prognosis for 2024

January 31, 2024

MedTech stocks have had plenty of reason to rally over the last year but haven't. That is about to change with growth accelerating in 2024 and 2025.

Via MarketBeat

7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market ↗

January 28, 2024

Aging is an inevitability, as much as we try to deny it. Under this context, these AgeTech stocks may prove quite relevant.

Via InvestorPlace

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.